Sinovac Biotech Ltd (NASDAQ:SVA)

--
Real-Time Quote
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line515.0K-3.1M36.7M36.1M
 
 
 
 
 
Depreciation6.5M5.1M4.6M4.9M
 
 
 
 
 
Total Other Cash Flow510.0K3.8M3.3M7.8M
 
 
 
 
 
Funds From Operations7.0M4.8M39.7M51.9M
 
 
 
 
 
Funds From/For Other Operating Expenses2.7M18.7M-20.0M44.0M
 
 
 
 
 
Net Cash Flow - Operating Activities4.3M-13.9M59.8M7.9M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-19.7M
 
 
Capital Expenditures-5.3M-12.7M-11.9M-5.6M
 
 
 
 
 
Fixed Asset Disposal882.0K887.0K19.0K22.0K
 
 
 
 
 
Other Investing - Uses-98.0K-9.0K0.000.00
 
 
 
Net Cash Flow Investing-4.5M-11.8M-11.9M-25.3M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings21.3M0.000.000.00
 
 
Long Term Debt Reduction-46.8M0.000.000.00
 
 
Net Proceeds Stock Sale750.0K315.0K1.7M85.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----0.00----
Cash Dividends Paid - Total--0.000.000.00--
Other Sources - Financing544.0K6.9M2.6M3.8M
 
 
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-24.2M27.8M-1.3M64.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.5M-2.1M3.9M-4.7M
 
 
 
 
 
 
Net Change In Cash-24.4M2.1M46.5M46.9M